MedTrace Logo

Effect of Bacillus Subtilis DE111® on Daily Bowel Movements

NCT04083521 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2019-09-10

No results posted yet for this study

Summary

The purpose of this study is to determine the efficacy of Bacillus subtilis DE111® probiotic for regulation of bowel movements.

Conditions

  • Bowel Movement Regulation
  • Occasional Constipation
  • Occasional Diarrhea

Interventions

DIETARY_SUPPLEMENT

Bacillus subtilis DE111®

Subjects were administered a dose of Bacillus subtilis at levels of 1x10\^9 CFU once a day for 90-days.

Sponsors & Collaborators

  • Kennesaw State University

    collaborator OTHER

  • Deerland Enzymes

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-09-01
Primary Completion
2017-08-31
Completion
2017-08-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04083521 on ClinicalTrials.gov